AVTX (Avalo Therapeutics, Inc.) Sof foyda

AVTX (Avalo Therapeutics) - kompaniyaning tovar belgisi

Avalo Therapeutics, Inc (AVTX) noyob immun patologiyalariga qarshi dori vositalarini ishlab chiqadi. Foyda potentsiali kompaniyaga terapiya xarajatlari bo'yicha narxlarni belgilash imkoniyatini beruvchi eksklyuziv patentlarga asoslangan. Narxlar dinamikasi (separate_profit) foyda ko'rsatkichlarini aks ettiradi, ular hozirda -0.10 darajasida turibdi. Biznes barqarorligi olimlarning sodiq xodimlari va klinik sinovlar ekspertlarini faol jalb qilish orqali ta'minlanadi, bu esa intellektual kapitalning chiqib ketishining oldini oladi.

AVTX (Avalo Therapeutics, Inc) Sof foyda tarixi 04.07.2022dan 01.11.2026gacha

Avalo Therapeutics (AVTX) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Avalo Therapeutics Inc|AVTX - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Avalo Therapeutics Inc|AVTX - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Avalo Therapeutics|AVTX - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi avalotx.com|AVTX - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Avalo Therapeutics, Inc|AVTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Avalo Therapeutics, Inc.|AVTX - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Avalo Therapeutics Inc|AVTX - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Avalo Therapeutics|Shoshilinch likvidlik avalotx.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
AVTX - Sof foyda
Kompaniyaning jamlanma tahlili:Avalo Therapeutics, Inc
Avalo Therapeutics Inc. asosiy tovari

Avalo Therapeutics, Inc (AVTX) yallig'lanish patologiyalari uchun yuqori xarajatli klinik sinovlarga e'tibor qaratadi. Ushbu ko'rsatkich uzoq muddatli tendentsiyani aniqlash uchun qisqa muddatli bozor shovqinlarini tekislagan holda kunlik sof foydani aks ettiradi. Kompaniyaga tegishli foydani tahlil qilish barcha operatsion xarajatlar chegirilgandan keyingi haqiqiy moliyaviy natijani baholash imkonini beradi. Doimiy R&D xarajatlari va marginal kengayish imkoniyatining yo'qligini hisobga olgan holda, chiziqli tebranishlar xatarlardan signal beradi. Barqaror o'sish esa kapital barqarorligini tasdiqlaydi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|PHAR - Sof foyda|NKTR (Nektar Therapeutics) - Sof daromad|UPB (upstreambio.com) - Kompaniyaning sof foydasi|ZBIO (Zenas Biopharma) - Sof foyda|Sof foyda Immunome Inc|Kompaniyaning sof foydasi Gossamer Corp (GOSS)|Kompaniyaning sof foydasi KALV (KalVista Corp)|Kompaniyaning sof foydasi Septerna Inc SEPN|pieris.com (PVLA) - Kompaniyaning sof daromadi|SVRA: Sof daromad|Yakuniy foyda RIGL (Rigel Pharma)|ANAB (AnaptysBio Corp) - Sof daromad|ATXS: Soliqlar to‘langandan keyingi foyda|ENGN (enGene Holdings Inc.) - Sof foyda|RAPT: Yakuniy foyda|Sof foyda JBIO|ACRS - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Kyverna KYTX|Yakuniy foyda TLSA|Cabaletta Bio, Inc. - Sof foyda|VTYX - Sof foyda|Theratechnologies (THTX) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda ELDN (Eledon Pharmaceuticals Inc.)|AGEN (Agenus Inc) - Sof foyda|Kompaniyaning sof daromadi Climb Bio, Inc CLYM|Sof daromad ZURA (Zura Bio Limited)|Sof foyda atyrpharma.com (ATYR)|Adagene Inc. - Sof daromad|Soliqlar to‘langandan keyingi foyda IMA (ImageneBio)|Shattuck Therapeutics - Sof foyda|Sof moliyaviy natija Equillium, Inc. EQ|CNTB: Sof foyda|Sof daromad Immunic|Kompaniyaning sof foydasi Atara Biotherapeutics, Inc.|InflaRx GmbH (IFRX) - Sof moliyaviy natija|Sof daromad XFOR (X4 Pharma)|ACET (adicetbio.com) - Yakuniy foyda|Sof foyda CELU (Celularity)|Sof moliyaviy natija inmunebio.com (INMB)|BRNS - Kompaniyaning sof foydasi|KZR (Kezar Life Sciences Inc.) - Kompaniya foydasi|SABS: Sof foyda|Sof daromad Akari Therapeutics, Plc|ENLV (Enlivex Therapeutics Ltd) - Sof foyda|Sof foyda Q32 Bio Corp|Sof daromad GOVX (GeoVax)|Kompaniyaning sof foydasi EDSA (Edesa Biotech Inc)|iBio Corp - Sof daromad|Soliqlar to‘langandan keyingi foyda CARM (Carisma Therapeutics Inc)|XTLB: Sof daromad|BOLT (Bolt Biotherapeutics) - Kompaniya foydasi|hcwbiologics.com (HCWB) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda APVO (Aptevo Therapeutics Inc.)|AIM (AIM ImmunoTech) - Sof foyda|ADTX: Yakuniy foyda|Sof foyda GRI|Sof foyda xortx.com (XRTX)|Kompaniyaning sof foydasi Vyome Holdings HIND|Yakuniy foyda REVB|INDP - Kompaniyaning sof foydasi|BiondVax Pharmaceuticals (SCNI) - Sof daromad|CALI: Sof foyda|Affimed N.V. (AFMD) - Sof foyda|Sof daromad ALLK|HOOK: Yakuniy foyda|Sof foyda IGMS|Sof moliyaviy natija iTeos Pharma|Kompaniyaning sof foydasi Ocean Biomedical, Inc. OCEA|TCBP - Sof daromad|THRD - Kompaniyaning sof foydasi